SOUTH AFRICA PHARMACEUTICAL INDUSTRY EXPANSION INDIA COMPETITION ASPEN AIDS DRUGS
January 1st, 2006
BY STEVEN SWINDELLS, in Johannesburg
SOUTHERN Africa's leading generic drugs manufacturer Aspen is confident that it can capitalise on the increasing take up of life-prolonging generic anti-retroviral (ARV) drugs, in the fight against HIV-AIDS. But industry analysts have questioned demand forecasts for ARVs and warn that rival Indian generic manufacturers could be a threat to Aspen's market ambitions.
Southern Africa's generics drug market is expanding as governments of some of the world's poorest countries move to boost ARV treatment as part of health ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.